Clinical Trial Update: High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating high-dose cytarabine in combination with deoxycytidine for acute myeloid leukemia and other hematologic malignancies;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Lymphoma
• Multiple Myeloma

Drugs mentioned

• Cytarabine (high-dose) (cytarabine)
• Deoxycytidine (2'-deoxycytidine)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Drug/Agent Toxicity by Tissue/Organ, Leukemia | Phase 1 | Status: COMPLETED